克洛菲布拉特诱导的血清肌酸酸酶水平的增加.

Characterization of new mutations in the 5'-flanking region of the familial Mediterranean fever gene.

Genes and immunity·2009

Early and severe amyloidosis in a patient with concurrent familial Mediterranean fever and pseudoxanthoma elasticum.

The British journal of dermatology·2006

[Hereditary hyperferritinemia syndrome and cataract].

Journal francais d'ophtalmologie·2002

MEFV mutations and phenotype-genotype correlations in North African Jews and Armenians with familial Mediterranean fever.

The Israel Medical Association journal : IMAJ·2001

The MICA region determines the first modifier locus in familial Mediterranean fever.

Arthritis and rheumatism·2001

Mutations in the MEFV gene in a large series of patients with a clinical diagnosis of familial Mediterranean fever.

American journal of medical genetics·2000

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Association between the C-reactive protein-triglyceride-glucose index and the presence and prognosis of coronary microvascular dysfunction in patients with chronic coronary syndrome.

Frontiers in cardiovascular medicine·2026

Postprandial Metabolite and Antioxidant Kinetics Following Intake of a Carob Beverage in Healthy Males.

Nutrients·2026

Circulating β-Hydroxybutyrate in Glycemic Progression and Diabetic Cardiomyopathy: Adaptive Signal or Maladaptive Substrate?

International journal of molecular sciences·2026

Microbiota-dependent biotransformation of apiin drives butyrate-associated protection against colitis.

NPJ science of food·2026

Characteristics of gut microbiota structure and composition in diabetic patients from the Chaoshan region of China.

Journal of medical microbiology·2026

The Gluco-Vascular Injury Axis in Diabetic Cardiovascular Dysfunction: A Narrative Review.

Cureus·2026

相关实验视频

克洛菲布拉特诱导的血清肌酸酸酶水平的增加.

相关概念视频

Characterization of new mutations in the 5'-flanking region of the familial Mediterranean fever gene.

Early and severe amyloidosis in a patient with concurrent familial Mediterranean fever and pseudoxanthoma elasticum.

[Hereditary hyperferritinemia syndrome and cataract].

MEFV mutations and phenotype-genotype correlations in North African Jews and Armenians with familial Mediterranean fever.

The MICA region determines the first modifier locus in familial Mediterranean fever.

Mutations in the MEFV gene in a large series of patients with a clinical diagnosis of familial Mediterranean fever.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Association between the C-reactive protein-triglyceride-glucose index and the presence and prognosis of coronary microvascular dysfunction in patients with chronic coronary syndrome.

Postprandial Metabolite and Antioxidant Kinetics Following Intake of a Carob Beverage in Healthy Males.

Circulating β-Hydroxybutyrate in Glycemic Progression and Diabetic Cardiomyopathy: Adaptive Signal or Maladaptive Substrate?

Microbiota-dependent biotransformation of apiin drives butyrate-associated protection against colitis.

Characteristics of gut microbiota structure and composition in diabetic patients from the Chaoshan region of China.

The Gluco-Vascular Injury Axis in Diabetic Cardiovascular Dysfunction: A Narrative Review.

相关实验视频

克洛菲布拉特诱导的血清肌酸酸酶水平的增加.

相关概念视频

相关文章